The race is on
The ICR and The Royal Marsden have ambitious plans to ensure that research into treatments, diagnostics and prevention is rapidly adopted into routine healthcare
Share this article
25,000
women benefit annually from reduced side effects thanks to START trials
"Our new research strategy emphasises getting advances in cancer treatment, diagnosis and prevention embedded into the clinic as part of routine care"
Joining forces
Professor Harrington will lead a collaborative project that aims to put three ground-breaking radiotherapy technologies into routine practice